SCHEDULE OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Revenues	$ 16,546		$ 36,608		$ 60,377	$ 157,618
Operating loss	(302,589)				(611,311)
Unallocated costs	(563,619)				(1,153,963)
Total operating loss	(866,208)		(840,318)		(1,765,274)	(2,583,972)
Financing expenses, net	(81,055)				(76,119)
Other income	117,396		12,294		105,225	12,294
Changes in fair value of an investment in an associate measured under the fair value option	29,725				113,668
Net loss	(800,142)	$ (822,358)	$ (714,935)	$ (1,721,549)	(1,622,500)	$ (2,436,484)
Pathogen Prevention [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	16,546				60,377
Operating loss	(283,778)				(474,561)
Global Warming Solutions [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues
Operating loss	$ (18,811)				$ (136,750)